review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1177/1753465810361359 |
P698 | PubMed publication ID | 20215487 |
P2093 | author name string | Carolyn Kercsmar | |
P2860 | cites work | Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults | Q24242904 |
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial | Q24655820 | ||
Exhaled nitric oxide measurements: clinical application and interpretation | Q24678480 | ||
Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide | Q30436056 | ||
Reference values for exhaled nitric oxide (reveno) study. | Q30499270 | ||
Increased nitric oxide in exhaled air of asthmatic patients | Q34321842 | ||
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 | ||
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years | Q34424366 | ||
Reference ranges for exhaled nitric oxide derived from a random community survey of adults | Q34625434 | ||
The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial | Q34627601 | ||
Exhaled nitric oxide in childhood asthma: a review | Q34724840 | ||
Multiple roles of nitric oxide in the airways. | Q35055532 | ||
Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols | Q35088211 | ||
Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma | Q35534832 | ||
Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission | Q35537520 | ||
Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests | Q35564195 | ||
The arginine-arginase balance in asthma and lung inflammation | Q36386798 | ||
Nitric oxide as a clinical guide for asthma management | Q36388264 | ||
Exhaled biomarkers | Q36651025 | ||
Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4. | Q37100900 | ||
Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma | Q37142937 | ||
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice | Q37522916 | ||
Cluster analysis and clinical asthma phenotypes. | Q37711387 | ||
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics | Q40315613 | ||
Physiologic measures: pulmonary function tests. Asthma outcome | Q40809843 | ||
Role of nasal nitric oxide in the resolution of experimental rhinovirus infection | Q43538398 | ||
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group | Q44104022 | ||
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. | Q44247874 | ||
Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma | Q44357077 | ||
Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children | Q44650811 | ||
Heterogeneity of FeNO response to inhaled steroid in asthmatic children | Q44680438 | ||
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma | Q46220581 | ||
Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma | Q46309541 | ||
Exhaled nitric oxide: a predictor of steroid response | Q46496987 | ||
Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial | Q46565002 | ||
Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height | Q47238546 | ||
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. | Q47727199 | ||
High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children | Q47766190 | ||
Exhaled nitric oxide as a screening tool for asthma in school children | Q47799251 | ||
Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children | Q47849250 | ||
The use of exhaled nitric oxide in the diagnosis of asthma in school children | Q48402544 | ||
Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. | Q50776015 | ||
Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
Transient decrease of exhaled nitric oxide after acute exposure to passive smoke in healthy subjects. | Q51681858 | ||
Development and validation of a questionnaire to measure asthma control. | Q53341478 | ||
Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. | Q54423561 | ||
Selective Inducible Nitric Oxide Synthase Inhibition Has No Effect on Allergen Challenge in Asthma | Q58864341 | ||
P433 | issue | 2 | |
P921 | main subject | asthma | Q35869 |
diagnosis | Q16644043 | ||
P304 | page(s) | 71-82 | |
P577 | publication date | 2010-03-09 | |
P1433 | published in | Therapeutic advances in respiratory disease | Q26842252 |
P1476 | title | Exhaled nitric oxide in the diagnosis and management of childhood asthma | |
P478 | volume | 4 |
Q37864705 | Biomarkers of therapy responsiveness in asthma: pitfalls and promises |
Q39025584 | Exhaled nitric oxide in the diagnosis of asthma in adults: a systematic review. |
Q35044372 | Exhaled nitric oxide is related to atopy, but not asthma in adolescents with bronchiolitis in infancy |
Q37837908 | Inflammatory markers in childhood asthma |
Q36198171 | Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptoms |
Q37955802 | Measures of asthma control |
Q45004469 | Nasal NO as a biomarker: don't say NO to the many challenges of translational medicine |
Q37812543 | Respiratory Viruses, Eosinophilia and Their Roles in Childhood Asthma |
Q36846745 | Role of exhaled nitric oxide as a predictor of atopy |
Search more.